- Home
- DAWN vs ASM Comparison
DAWN vs ASM Comparison
Compare DAWN & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- ASM
- Stock Information
- Founded
- DAWN 2018
- ASM 1968
- Country
- DAWN United States
- ASM Canada
- Employees
- DAWN N/A
- ASM N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- ASM Metal Mining
- Sector
- DAWN Health Care
- ASM Basic Materials
- Exchange
- DAWN Nasdaq
- ASM Nasdaq
- Market Cap
- DAWN 624.8M
- ASM 612.8M
- IPO Year
- DAWN 2021
- ASM N/A
- Fundamental
- Price
- DAWN $7.19
- ASM $4.46
- Analyst Decision
- DAWN Strong Buy
- ASM Strong Buy
- Analyst Count
- DAWN 7
- ASM 3
- Target Price
- DAWN $27.86
- ASM $3.73
- AVG Volume (30 Days)
- DAWN 1.1M
- ASM 5.3M
- Earning Date
- DAWN 10-29-2025
- ASM 11-11-2025
- Dividend Yield
- DAWN N/A
- ASM N/A
- EPS Growth
- DAWN N/A
- ASM 1940.36
- EPS
- DAWN N/A
- ASM 0.11
- Revenue
- DAWN $187,638,000.00
- ASM $79,639,000.00
- Revenue This Year
- DAWN $12.56
- ASM $33.26
- Revenue Next Year
- DAWN $48.02
- ASM $27.16
- P/E Ratio
- DAWN N/A
- ASM $41.46
- Revenue Growth
- DAWN 2190.50
- ASM 53.08
- 52 Week Low
- DAWN $5.64
- ASM $0.85
- 52 Week High
- DAWN $16.76
- ASM $4.75
- Technical
- Relative Strength Index (RSI)
- DAWN 52.01
- ASM 61.15
- Support Level
- DAWN $7.18
- ASM $4.00
- Resistance Level
- DAWN $7.58
- ASM $4.30
- Average True Range (ATR)
- DAWN 0.27
- ASM 0.24
- MACD
- DAWN -0.03
- ASM -0.01
- Stochastic Oscillator
- DAWN 33.92
- ASM 62.11
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.